Emas Medsp. z o.o.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2023-06-07
Share capital
5,000.00 PLN
Activity description

Emas Med coordinates access to treatment in Israel and Switzerland and offers remote consultations for medical second opinions. The company provides access to genetic tests and clinical trials, with specialties including oncology, orthopedics, urology, cardiology and gynecology.

Registered address
ul. Jana Heweliusza 11/811, 80-890 Gdańsk, Poland
Website
emasmed.com
Opening hours
Monday–Friday
9:00–18:00
Saturday–Sunday
9:00–12:00
Email
Phone
Social media

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history

Filing timeliness

1 of 3 financial statements was filed late (for 2025, 22 days late).

  • 202506/08/2026
  • 202410/07/2025
  • 202301/07/2024
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

News

ASCO 2026: Breakthrough Results in Treatment of Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

ASCO 2026: Breakthrough Results in Treatment of Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Second Chance at Life Thanks to World-Class Global Medicine

Second Chance at Life Thanks to World-Class Global Medicine

Breakthrough in Rectal Cancer Treatment – Will Surgery Become Unnecessary?

Breakthrough in Rectal Cancer Treatment – Will Surgery Become Unnecessary?

Medical Pioneers: Israel as a Global Leader in CAR-T Cell Therapy

Medical Pioneers: Israel as a Global Leader in CAR-T Cell Therapy

Ranking of the Best Specialist Doctors in Israel in 2023

Ranking of the Best Specialist Doctors in Israel in 2023

Over 120 New Drugs Planned for Introduction in Israel in 2023

Over 120 New Drugs Planned for Introduction in Israel in 2023

Industry

Offer

  • Treatment coordination
  • Second medical opinion
  • Genetic testing
  • Cancer treatment
  • Orthopedic treatment
  • Urological treatment
  • Cardiac treatment
  • Physician training

Website technology

Website
  • WordPress

Authorized Representatives

Elena Malt – President of the Management Board
Rita Tager – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Elena Maltage 51
50$675.3150%
Rita Tagerage 71
50$675.3150%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Bella Pharmasp. z o.o.
Aura Medicsp. z o.o.
Fudeko Medsp. z o.o.
NewmedicalS.A.
Centrum Mostysp. z o.o.
Logopasjasp. z o.o.
Miofunkcjasp. z o.o.
Diagnosteosp. z o.o.
Dobre Kaloriesp. z o.o.
Jkmed Medycyna Pracysp. z o.o.

Change history

DateEvent
2024-02-22Address change
2023-06-07Entered in the register

FAQ

Last updated: 2026-08-06